Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome.

Link to article at PubMed

Related Articles

Neuromuscular Blockers in Early Acute Respiratory Distress Syndrome.

N Engl J Med. 2010 Sep 16;363(12):1107-1116

Authors: Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal JM, Perez D, Seghboyan JM, Constantin JM, Courant P, Lefrant JY, Guérin C, Prat G, Morange S, Roch A

The investigators induced muscle paralysis in patients with the acute respiratory distress syndrome (ARDS) by administering a neuromuscular blocking agent, cisatracurium besylate. As compared with placebo, cisatracurium resulted in a lower adjusted 90-day mortality without more severe sequelae of neuromuscular blockade.

PMID: 20843245 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *